play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left
  • cover play_arrow

    Welcome to Online Radio
    The Leading Lifestyle Internet Radio

  • cover play_arrow

    Music 24/7 - Africana
    Online Radio

  • cover play_arrow

    Music 24/7 - International
    Online Radio

  • cover play_arrow

    Music 24/7 - Gospel
    Online Radio

  • cover play_arrow

    Music 24/7 - Latin America
    Online Radio

  • cover play_arrow

    Talk Shows - Stay Updated
    Online Radio

  • cover play_arrow

    Pillars and Plants - Gospel
    Online Radio

  • cover play_arrow

    Audio Stories - A new movie experience
    Online Radio

  • Home
  • keyboard_arrow_right Sports
  • keyboard_arrow_right UCL: Varane To Miss Liverpool Encounter After Contracting COVID-19

Sports

UCL: Varane To Miss Liverpool Encounter After Contracting COVID-19

Oluwaseye Ogunsanya April 6, 2021 38


Background
share close

Real Madrid defender, Raphael Varane has tested positive for COVID-19, he will thereby miss Tuesday’s UEFA Champions League (UCL) clash against Liverpool.

Real Madrid announced the 27-year-old French footballer’s COVID-19 status in a short statement on its website.

“Real Madrid C. F. informs that our player Raphaël Varane tested positive in the COVID-19 test he underwent this morning,” the statement read.

Real Madrid are scheduled to face Liverpool in the first leg of their quarter-finals tie at the Alfredo Di Stefano stadium.

Varane’s absence adds to the growing injury list for Zinedine Zidane’s side. The defender has featured in all eight UCL matches this season.

The Frenchman is already without Sergio Ramos due to an injury sustained during the international duty with Spain.

The 13-time UCL winners are left with Eder Militao and Nacho as the only two senior central defenders available for the clash.

Real Madrid previously defeated Liverpool 3-1 in the 2018 UCL final.

Tagged as: , , , , .

Rate it
Previous post
Post comments (0)

Leave a reply